[go: up one dir, main page]

GR3001922T3 - Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration - Google Patents

Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration

Info

Publication number
GR3001922T3
GR3001922T3 GR91400534T GR910400534T GR3001922T3 GR 3001922 T3 GR3001922 T3 GR 3001922T3 GR 91400534 T GR91400534 T GR 91400534T GR 910400534 T GR910400534 T GR 910400534T GR 3001922 T3 GR3001922 T3 GR 3001922T3
Authority
GR
Greece
Prior art keywords
amino acid
peptides
oral
bis
cystin
Prior art date
Application number
GR91400534T
Other languages
English (en)
Inventor
Peter Dr Stehle
Peter Prof Dr Fuerst
Werner Dr Dr H C Fekl
Original Assignee
Pfrimmer Kabi Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfrimmer Kabi Gmbh & Co Kg filed Critical Pfrimmer Kabi Gmbh & Co Kg
Publication of GR3001922T3 publication Critical patent/GR3001922T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
GR91400534T 1986-10-24 1991-05-09 Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration GR3001922T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3636334 1986-10-24

Publications (1)

Publication Number Publication Date
GR3001922T3 true GR3001922T3 (en) 1992-11-23

Family

ID=6312449

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91400534T GR3001922T3 (en) 1986-10-24 1991-05-09 Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration

Country Status (9)

Country Link
US (1) US4968696A (el)
EP (1) EP0264953B1 (el)
JP (1) JPH01501706A (el)
AT (1) ATE63316T1 (el)
AU (1) AU605214B2 (el)
DE (1) DE3769910D1 (el)
ES (1) ES2039402T3 (el)
GR (1) GR3001922T3 (el)
WO (1) WO1988003150A2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402931B (de) * 1986-11-07 1997-09-25 Pharmacia Gmbh Verfahren zur herstellung von neuen cystinverbindungen und derenverwendung
US5102871A (en) * 1989-04-24 1992-04-07 Kyowa Hakko Kogyo Co., Ltd. Nutrient composition
DK53191D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK0545198T3 (da) * 1991-11-29 2000-03-20 Hoechst Ag Peptider med insulinagtig virkning
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
FR2872042B1 (fr) * 2004-06-29 2006-09-15 Soc Extraction Principes Actif Utilisation d'un dipeptide dimerise en tant qu'agent actif dans ou pour la preparation une composition cosmetique et/ou dermatologique
JP5668271B2 (ja) * 2008-12-25 2015-02-12 ユーハ味覚糖株式会社 シスチン−アミノ酸複合体及びその製造方法
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
EP2610338A4 (en) 2010-08-02 2015-03-25 Kyowa Hakko Kirin Co Ltd PROCESS FOR PRODUCTION OF SUBSTANCE
US20230200424A1 (en) * 2020-04-20 2023-06-29 Evonik Operations Gmbh Compositions comprising cys-peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL245033A (el) * 1900-01-01
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
BE785933A (fr) * 1971-07-07 1973-01-08 Ciba Geigy Procede de preparation de peptides contenant de la cystine
US4258193A (en) * 1978-07-13 1981-03-24 Toyo Jozo Kabushiki Kaisha Disulfide derivatives having S--S exchange reactivity
US4284624A (en) * 1980-05-02 1981-08-18 E. R. Squibb & Sons, Inc. Mixed disulfides
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
US4427582A (en) * 1982-06-08 1984-01-24 Smithkline Beckman Corporation Antimicrobial disulfide prodrugs

Also Published As

Publication number Publication date
JPH01501706A (ja) 1989-06-15
US4968696A (en) 1990-11-06
DE3769910D1 (de) 1991-06-13
ES2039402T3 (es) 1993-10-01
WO1988003150A2 (en) 1988-05-05
AU605214B2 (en) 1991-01-10
EP0264953B1 (de) 1991-05-08
WO1988003150A3 (en) 1988-07-14
AU8230187A (en) 1988-05-25
EP0264953A2 (de) 1988-04-27
EP0264953A3 (en) 1988-08-31
ATE63316T1 (de) 1991-05-15

Similar Documents

Publication Publication Date Title
AU594488B2 (en) Agents for the treatment of arthroses
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
DK119785D0 (da) Insulinpraeparat
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
FI904074A7 (fi) Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
TR199501630A2 (tr) Peptid p277 benzerleri ve diagnoz ve dibetlerin'lerin tedavisi icin onlari iceren kompozisyonlar.
GR3001922T3 (en) Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration
GR852541B (el)
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
DK0714910T3 (da) Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
AU9625498A (en) Organ specific nutrition
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
DE59709066D1 (de) Mittel zur dauerhaften Verformung von menschlichen Haaren
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
DE69534740D1 (en) Analoge des thymosin alpha 1
ES2015772A6 (es) Procedimiento e obtencion de nuevos derivados del 5-fluorouracilo, concretamente los n1-acil-sustituidos-n3-orto-toluil-5-fluorouracilo.
DK540087A (da) Peptidpraeparat